Next: Bibliography by alphabetical order
@old@biblabelbiblabel
- Bibliography by alphabetical order
- A
- G. Andrieu, Confidence intervals of evolutionary distances
between sequences and comparison with usual approaches including the
bootstrap method (1997)
- E. P. Acosta, The promise of therapeutic drug monitoring in
HIV infection (1999)
- L. Andersson, Concerted evolution in a segment of the first
domain exon of polymorphic MHC class II beta loci (1991)
- L. Andersson, Concerted evolution of polymorphic MHC class II
beta loci: a comment to reviewer's reply [letter] (1991)
- J. Adachi, Instability of quartet analyses of molecular
sequence data by the maximum likelihood method: the Cetacea/Artiodactyla
relationships (1996)
- R. M. Anderson, Infectious Diseases of Humans (1991)
- G. E. A, Function-structure analysis of proteins using
covarion-based evolutionary approaches: Elongation factors (2001)
- K. B. Athreya, Branching Processes (1972)
- S. Andersson, Molecular characterization of human
immunodeficiency virus (HIV)-1 and -2 in individuals from guinea-bissau with
single or dual infections: predominance of a distinct HIV-1 subtype A/G
recombinant in West Africa. (1999)
- a. anonymous, BRITISH HIV ASSOCIATION (BHIVA) GUIDELINES FOR
THE TREATMENT OF HIV-INFECTED ADULTS WITH ANTIRETROVIRAL THERAPY ()
- a. anonymous, Guidelines for the Use of Antiretroviral Agents
in HIV-Infected Adults and Adolescents ()
- a. anonymous, HIV-1 Vaccine Think Tank (1997)
- a. anonymous, Off drugs and no viral rebound (1997)
- a. anonymous, The perils of discontinuing therapy: without
HAART, cytokines stimulate HIV from latently infected cells. (1998)
- a. anonymous, HIV/AIDS Surveillance Report (1999)
- a. anonymous, Institute of Human Virology 1999 Meeting
Abstracts [selected pages]. (1999)
- a. anonymous, Pulsed therapy and structured interruptions of
treatment. (1999)
- a. anonymous, Study: HIV cannot be eradicated from body (1999)
- a. anonymous, Chapter 4: Bootstrap Confidence Sets and
Hypthesis Tests (2000)
- a. anonymous, Clinical Guidelines (2000)
- J. W. Archie, Homoplasy Excess Ratios: New Indices for
Measuring Levels of Homoplasy in phylogenetic Systematics and a Critique of
the Consistency Index (1989)
- M. Andreoni, Saquinavir delays the emergence of zidovudine
resistance in HIV-1 seropositive patients treated with combination therapy.
(1998)
- R. Aaziz, Recombination in RNA viruses and in virus-resistant
transgenic plants (1999)
- B
- A. G. Bedeian, A Program for computing Fisher's Exact
Probability Test and the Coefficient of Association l for n x m Contingency
Tables (1977)
- M. Balter, Can immune systems be trained to fight HIV? [news]
(1999)
- K. Bebenek, Specificity and mechanism of error-prone
replication by human immunodeficiency virus-1 reverse transcriptase (1989)
- A. . Barry, Will Viruses Succumb to Mathematical Models (1999)
- M. L. Bosch, Insertion of N-Linked Glycosylation Sites in the
Variable Regions of the Human Immunodeficiency Virus Type 1 Surface
Glycoprotein through AAT Triplet Reiteration. (1994)
- K. Bebenek, Error-prone polymerization by HIV-1 reverse
transcriptase (1993)
- N. G. Becker, Threshold parameters for epidemics in different
community settings (1995)
- J. C. Boyer, Unequal human immunodeficiency virus type 1
reverse transcriptase error rates with RNA and DNA templates (1992)
- K. Bebenek, The base substitution fidelity of HIV-1 reverse
transcriptase on DNA and RNA templates probed with 8-oxo-deoxyguanosine
triphosphate (1999)
- B. Bittner, Virus Load and Antigenic Diversity. (1997)
- M. Belshan, Genetic and biological variation in equine
infectious anemia virus Rev correlates with variable stages of clinical
disease in an experimentally infected pony (2001)
- C. T. H. Baker, Mathematical Modelling Of The Interleukin-2
T-Cell System: A Comparative Study Of Approaches Based On Ordinary And Delay
Differential Equations (1997)
- S. Bonhoeffer, Human Immunodeficiency Virus Drug Therapy and
Virus Load. (1997)
- P. J. Bickel, Covariability of V3 Loop Amino Acids (1996)
- A. Bobkov, Complex Mosaic Structure of the Partial Envelope
Sequence from a Gambian HIV Type 1 Isolate (1996)
- H. J. Bandelt, Split decomposition: a new and useful approach
to phylogenetic analysis of distance data (1992)
- S. M. Blower, Sensitivity and Uncertainty Analysis of Complex
Models of Disease Transmission: an HIV Model, as an Example (1993)
- N. G. Becker, The effect of household distribution on
transmission and control of highly infectious diseases (1995)
- S. M. Berman, A Stochastic Model for the Distribution of HIV
Latency Time Based on T4 Counts. (1990)
- B. Berkhout, HIV-1 evolution under pressure of protease
inhibitors: climbing the stairs of viral fitness. (1999)
- P. Beerli, Maximum-likelihood estimation of migration rates
and effective population numbers in two populations using a coalescent
approach (1999)
- P. Beerli, Maximum likelihood estimation of a migration
matrix and effective population sizes in n subpopulations by using a
coalescent approach (2001)
- J. J. Bailey, A kinetic model of CD4+ lymphocytes with the
human immunodeficiency virus (HIV). (1992)
- J. J. Bailey, A kinetic model of CD4+ lymphocytes with the
human immunodeficiency virus (HIV). (1992)
- P. D. Bieniasz, Highly divergent lentiviral Tat proteins
activate viral gene expression by a common mechanism (1999)
- J. Besag, Bayesian computation and stochastic systems (1995)
- T. P. Burris, The Gene Responsible for Adrenal Hypoplasia
Congenita, DAX-1, Encodes a Nuclear Hormone Receptor that Defines a New Class
Within the Superfamily (1996)
- A. J. Brown, Sequence clusters in human immunodeficiency
virus type 1 reverse transcriptase are associated with subsequent virological
response to antiretroviral therapy. (1999)
- D. Barry, Asynchronous distance between homologous DNA
sequence (1987)
- D. Barry, Statistical Analysis of Hominoid Molecular
Evolution (1987)
- W. J. Bruno, Topological Bias and Inconsistency of Maximum
Likelihood Using Wrong Models (1999)
- G. Bader, BIND-a data specification for storing and
describing biomolecular interactions, molecular complexes and pathways (2000)
- R. P. Bucy, Initial increase in blood CD4(+) lymphocytes
after HIV antiretroviral therapy reflects redistribution from lymphoid
tissues (1999)
- S. Bonhoeffer, Causes of HIV Diversity. (1995)
- M. Belshan, Biological characterization of Rev variation in
equine infectious anemia virus (1998)
- D. Boden, HIV-1 drug resistance in newly infected individuals
(1999)
- J. E. Blair, The evolutionary position of nematodes (2002)
- V. Brendel, Prediction of splice sites in plant pre-mRNA from
sequence properties (1998)
- A. Bobkov, A Sudden Epidemic of HIV Type 1 Among Injecting
Drug Users in the Former Soviet Union: Identification of Subtype A, Subtype
B, and Novel gagA/envB Recombinants (1998)
- A. Bobkov, Epidemic Expansion of HIV Type 1 Subtype C and
Recombinant Genotypes in Tanzania (1998)
- A. Bobkov, HIV type 1 gag D/env G recombinants in Russia (1998)
- R. Bartenschlager, Replication of hepatitis C virus (2000)
- C. A. Brennan, Serologic and phylogenetic characterization of
HIV-1 subtypes in Uganda (1997)
- A. L. Brown, Evolution of the structural proteins of human
immunodeficiency virus: selective constraints on nucleotide substitution (1988)
- G. Bleiber, Individual contributions of mutant protease and
reverse transcriptase to viral infectivity, replication, and protein
maturation of antiretroviral drug-resistant human immunodeficiency virus type
1 (2001)
- S. Bonhoeffer, Virus Dynamics and Drug Therapy. (1997)
- R. M. Berry, Defective Escape Mutants of HIV (1994)
- S. Bonhoeffer, Can Live Attenuated Virus Work as
Post-Exposure Treatment? (1995)
- S. Bonhoeffer, Pre-Existence and Emergence of Drug Resistance
in HIV-1 Infection. (1997)
- D. J. Balding, Detecting Gene Conversion: Primate Visual
Pigment Genes (1992)
- M. P. Busch, Factors influencing human immunodeficiency virus
type 1 transmission by blood transfusion. Transfusion Safety Study Group (1996)
- A. S. Bourinbaiar, HIV and gag (1991)
- B. Boyle, Should Ultra Sensitive Viral Load Assays be
Standard Practice (1999)
- A. M. Borman, Resistance of Human Immunodeficiency Virus Type
1 to Protease Inhibitors: Selection of Resistance Mutations in the Presence
and Absence of the Drug (1996)
- K. A. Barrie, Natural variation in HIV-1 protease, Gag p7 and
p6, and protease cleavage sites within gag/pol polyproteins: amino acid
substitutions in the absence of protease inhibitors in mothers and children
infected by human immunodeficiency virus type 1 (1996)
- A. M. Borman, A Highly Defective HIV-1 Group O Provirus:
Evidence for the Role of Local Sequence Determinants in G->A Hypermutaiton
during Negative-Strand Viral DNA Synthesis. (1995)
- K. Bremer, The Limits of Amino Acid Sequence Data in
Angiosperm Phylogenetic Reconstruction (1988)
- H. J. Bremermann, Mechanism of HIV persistence: implications
for vaccines and therapy (1995)
- S. M. Bruisten, Cellular Proviral HIV Type 1 DNA Load
Persists after Long-Term RT-Inhibitor Therapy in HIV Type 1 Infected Persons.
(1998)
- J. T. Blackard, Transmission of human immunodeficiency type 1
viruses with intersubtype recombinant long terminal repeat sequences (1999)
- E. Betran, The estimation of the number and the length
distribution of gene conversion tracts from population DNA sequence data (1997)
- J. K. M. Brown, Bootstrap Hypothesis Tests for Evolutionary
Trees and Other Dendograms (1994)
- A. J. Brown, Analysis of HIV-1 Env Gene Sequences Reveals
Evidence for a Low Effective Number in the Viral Population. (1997)
- N. Brown, Dynamics of HIV Infection in CD4+ T cells (1998)
- M. Birk, Variations in HIV-1 pol gene associated with reduced
sensitivity to antiretroviral drugs in treatment-naive patients. (1998)
- S. M. Bowyer, Relationships within and between genotypes of
hepatitis B virus at points across the genome: footprints of recombination in
certain isolates (2000)
- P. Balfe, Concurrent evolution of human immunodeficiency
virus type 1 in patients infected from the same source: rate of sequence
change and low frequency of inactivating mutations (1990)
- J. M. Binley, The relationship between T cell proliferative
responses and plasma viremia during treatment of human immunodeficiency virus
type 1 infection with combination antiretroviral therapy (2000)
- P. Baccam, PAQ: Partition Analysis of Quasispecies (2001)
- C. Brostrom, Longitudinal Quantification of Human
Immunodeficiency Virus Type 1 DNA and RNA in Long-Term Nonprogressors. (1999)
- D. L. Birx, Summary of track A: basic science (1996)
- Y. R. Borkowsky W, Proposed Protocol for Therapy Vacation. (1999)
- C
- J. A. Cavender, Mechanized derivation of linear invariants
[published erratum appears in Mol Biol Evol 1991 Mar;8(2):260] (1989)
- A. Carr, Adverse effects of antiretroviral therapy (2000)
- T. W. Chun, Quantification of Latent Tissue Reservoirs and
Total Body Viral Load in HIV-1 Infection. (1997)
- S. Cheng, Long PCR (1994)
- T. W. Chun, Re-Emergence of HIV after Stopping Therapy. (1999)
- T. W. Chun, Relationship between pre-existing viral
reservoirs and the re-emergence of plasma viremia after discontinuation of
highly active anti- retroviral therapy [see comments] (2000)
- T. W. Chun, Relationship between preexisting viral resevoir
and the reemergence of plasma viremia after discontinuation of highly active
antiretroviral therapy (2000)
- D. J. Choi, HIV type 1 Isolate Z321, the Strain Used to Make
a Therapeutic HIV Type 1 Immunogen, is Intersubtype Recombinant (1997)
- Y. Z. Cao, Identification and Quantitation of HIV-1 in the
Liver of Patients with AIDS (1992)
- D. A. Cooper, Latent Reservoirs of HIV infection: Flushing
with IL-2? (1999)
- T. W. Chun, Induction of HIV-1 Replication in Latently
Infected CD4+ T cells Using a Combination of Cytokines [published erratum
appears in J Exp Med 1998 Aug 3;188(3):following 614] (1998)
- T. W. Chun, Effect of Interleukin-2 on the Pool of Latently
Infected, Resting CD4+ T Cells in HIV-1-infected Patients Receiving Highly
Active Anti-retroviral Therapy. (1999)
- T. W. Chun, In vivo Fate of HIV-1-infected T cells:
Quantitative Analysis of the Transition to Stable Latency. (1995)
- R. W. Cone, Levels of HIV-infected peripheral blood cells
remain stable throughout the natural history of HIV-1 infection. Swiss HIV
Cohort Study (1998)
- Y. Chen, Conditional Inference on Zero-One Tables: A
Sequential Importance Sampling Approach (2001)
- R. Cheynier, Clonal expansion of T cells and HIV genotypes in
microdissected splenic white pulps indicates viral replication in situ and
infiltration of HIV-specific cytotoxic T lymphocytes. (1995)
- J. H. Condra, Genetic correlates of in vivo viral resistance
to indinavir, a human immunodeficiency virus type 1 protease inhibitor (1996)
- B. Charlesworth, Transposable Element Distributions in
Drosophila (1997)
- C. Cohen, Phenotypic Resistance Testing Significantly
Improves Response to Therapy (Tx): A Randomized Trial (VIRA 3001). Abstract
237 (2000)
- Carey, AIDS Drugs: Giving it a Rest (1999)
- K. A. Crandall, Parallel evolution of drug resistance in HIV:
failure of nonsynonymous/synonymous substitution rate ratio to detect
selection (1999)
- M. Cornelissen, Human immunodeficiency virus type 1 subtypes
defined by env show high frequency of recombinant gag genes. (1996)
- J. Carr, Characterization of subtype A HIV-1 from Africa by
full genome sequencing (1999)
- T. C, Modeling the covarion hypothesis of nucleotide
substitution (1998)
- C. Cheng-Mayer, Host Range, Replicative, and Cytopathic
Properties of Human Immunodeficiency Virus Type 1 are Determined by Very Few
Amino Acid Changes in tat and gp120. (1991)
- S. Corbet, env sequences of simian immunodeficiency viruses
from chimpanzees in Cameroon are strongly related to those of human
immunodeficiency virus group N from the same geographic area (2000)
- W. Cavert, Kinetics of Response in Lymphoid Tissues to
Antiretroviral Therapy of HIV-1 Infection [see comments] [published erratum
appears in Science 1997 May 30;276(5317):1321]. (1997)
- F. B. Christiansen, Waiting with and without recombination:
the time to production of a double mutant (1998)
- C. Cockerham, Variance of Gene Frequencies (1969)
- C. C. Cockerham, Analyses of Gene Frequencies (1973)
- J. M. Coffin, Genetic Diversity and Evolution of Retroviruses
(1992)
- J. M. Coffin, HIV population dynamics in vivo: implications
for genetic variation, pathogenesis, and therapy. (1995)
- J. Cohen, Looking for Leads in HIV's Battle with Immune
System (1997)
- C. Cohen, HIV/AIDS Treatment Updates - Current Management of
Antiretroviral Therapy in the HIV-1 Infected Patient (1998)
- S. W. Cole, T-cell Homeostasis: Blind or Far Sighted? (2000)
- J. H. Condra, Resistance to HIV protease inhibitors. (1998)
- R. A. Coutinho, Epidemiology: heterosexual transmission. (1996)
- K. A. Crandall, Intraspecific phylogenetics: support for
dental transmission of human immunodeficiency virus (1995)
- K. A. Crandall, Grant Application - Detection of
Recombination (2000)
- C. C. Clogg, Multiple Imputation of Industry and Occupation
Codes in Census Public-use Samples Using Bayesian Logistic Regression (1991)
- A. M. Caliendo, Effects of Zidovudine-Selected Human
Immunodeficiency Virus Type 1 Reverse Transcriptase Amino Acid Substitutions
on Processive DNA Synthesis and Viral Replication. (1996)
- J. K. Carr, Full genome sequences of human immunodeficiency
virus type 1 subtypes G and A/G intersubtype recombinants. (1998)
- J. H. Condra, In vivo Emergence of HIV-1 Variants Resistant
to Multiple Protease Inhibitors [see comments] (1995)
- J. K. Carr, Full-length sequence and mosaic structure of a
human immunodeficiency virus type 1 isolate from Thailand (1996)
- K. A. Crandall, Statistical Approaches to Detecting
Recombination (2000)
- C. W. Cunningham, Can three incongruence tests predict when
data should be combined? (1997)
- M. Cornelissen, pol gene diversity of five human
immunodeficiency virus type 1 subtypes: evidence for naturally occurring
mutations that contribute to drug resistance, limited recombination patterns,
and common ancestry for subtypes B and D. (1997)
- M. Cornelissen, Spread of distinct human immunodeficiency
virus type 1 AG recombinant lineages in Africa (2000)
- G. A. Churchill, Sample size for a phylogenetic inference (1992)
- A. Cleland, Evolution of zidovudine resistance-associated
genotypes in human immunodeficiency virus type 1-infected patients (1996)
- T. W. Chun, Presence of an Inducible HIV-1 Latent Reservoir
During Highly Active Antiretroviral Therapy. (1997)
- C. C. Chang, Evolution of Porcine Reproductive and
Respiratory Syndrome Virus during Sequential Passages in Pigs (2002)
- D
- F. Damond, HIV-1 Subtypes and Plasma RNA Quantification
[letter] (1999)
- R. T. Davey, Structured withdrawal of HAART in HIV-1-infected
patients (1999)
- R. J. Boer, Anti-CD4 Therapy for AIDS Suggested by
Mathematical Models. (1996)
- E. S. Daar, Acute HIV Syndrome After Discontinuation of
Antiretroviral Therapy in a Patient Treated Before Seroconversion. (1998)
- R. J. Boer, Target Cell Limited and Immune Control Models of
HIV Infection: A Comparison. (1998)
- R. T. Davey, HIV-1 and T cell dynamics after interruption of
highly active antiretroviraal therapy (HAART) in patients with a history of
sustained viral suppression (1999)
- L. Diaz, Human immunodeficiency virus reverse transcriptase
base misincorporations can promote strand transfer (2000)
- J. Durant, Drug-resistance genotyping in HIV-1 therapy: the
VIRADAPT randomised controlled trial [see comments] (1999)
- F. Dronda, Cross-Resistance to Nelfinavir Can Be Predicted by
Previous Antiretroviral Exposure in the Absence of D30N Mutation (2000)
- S. Delassus, Evolution of human immunodeficiency virus type 1
nef and long terminal repeat sequences over 4 years in vivo and in vitro (1991)
- G. Drouin, Independent gene evolution in the potato actin
gene family demonstrated by phylogenetic procedures for resolving gene
conversions and the phylogeny of angiosperm actin genes (1990)
- R. F. DuBose, Genetic exchange among natural isolates of
bacteria: recombination within the phoA gene of Escherichia coli (1988)
- J. Dopazo, Split decomposition: a technique to analyze viral
evolution (1993)
- L. M. Demeter, Interlaboratory Concordance of DNA Sequence
Analysis to Detect Reverse Transcriptase Mutations in HIV-1 Proviral DNA.
ACTG Sequencing Working Group. AIDS Clinical Trials Group. (1998)
- T. DiCiccio, More Accurate Confidence Intervals in
Exponential Families (1992)
- T. DiCiccio, Bootstrap Confidence Level (1996)
- S. G. Deeks, HIV/AIDS at IDSA: Report from the 37th Annual
Meeting of the Infectious Disease Society of America (1999)
- S. G. Deeks, Conference Report: Third International Workshop
on Salvage Therapy for HIV Infection (2000)
- S. G. Deeks, Optimizing Antiretroviral Therapy: Strategies
and Regimens (2000)
- D. Descamps, Mechanisms of virologic failure in previously
untreated HIV-infected patients from a trial of induction-maintenance
therapy. Trilege (Agence Nationale de Recherches sur le SIDA 072) Study Team)
[see comments] (2000)
- R. F. DuBose, The Molecular Evolution of Bacterial Alkaline
Phosphatase: Correlating Variation among Enteric Bacteria to Experimental
Manipulations of the Protein (1990)
- J. Dolezal, Influence of the Cell Interaction Parameters on
the Simulated CD4+ Lymphocyte Depletion in HIV Infection. (1991)
- S. G. Deeks, Novel Four-Drug Salvage Treatment Regimens After
Failure of a Human Immunodeficiency Virus type 1 Protease
Inhibitor-Containing Regimen: Antiviral Activity and Correlation of Baseline
Phenotypic Drug Susceptibility With Virologic Outcome. (1999)
- S. G. Deeks, HIV RNA and CD4 cell count response to protease
inhibitor therapy in an urban AIDS clinic: response to both initial and
salvage therapy (1999)
- P. D, Mathematical elegance with biochemical realism: the
covarion model of molecular evolution (2001)
- M. D. Jong, Overshoot of HIV-1 viraemia after early
discontinuation of antiretroviral treatment. (1997)
- M. D. Jong, Host-parasite Dynamics and Outgrowth of Virus
Containing a Single K70R Amino Acid Change in Reverse Transcriptase are
Responsible for the Loss of Human Immunodeficiency Virus Type 1 RNA Load
Suppression by Zidovudine. (1996)
- N. W. Douglas, An Efficient Method for the Rescue and
Analysis of Functional HIV-1 env Genes: Evidence for Recombination in the
Vicinity of the tat/rev Splice Site (1996)
- K. S. Dorman, Can structured treatment interruptions increase
the risk of drug resistant HIV-1? (2000)
- K. S. Dorman, Can structured treatment interruptions increase
the risk of drug resistant HIV-1? (2000)
- K. S. Dorman, Can structured treatment interruptions increase
the risk of drug resistant HIV-1? (2000)
- C. A. Derdeyn, Evaluation of distinct blood lymphocyte
populations in human immunodeficiency virus type 1-infected subjects in the
absence or presence of effective therapy. (1999)
- K. S. Dorman, Bootstrap confidence levels for HIV-1
recombination ()
- L. C. Carriere, Effects of human immunodeficiency virus type
1 resistance to protease inhibitors on reverse transcriptase processing,
activity, and drug sensitivity (1999)
- D. C. Douek, Changes in the thymic function with age and
uduring the treatment of HIV infection (1998)
- H. Doi, Importance of purine and pyrimidine content of local
nucleotide sequences (six bases long) for evolution of the human
immunodeficiency virus type 1. (2000)
- D. E. Dykhuizen, Borrelia burgdorferi is clonal: implications
for taxonomy and vaccine development (1993)
- G. Drouin, Detecting and characterizing gene conversions
between multigene family members (1999)
- E. L. Delwart, Rapid, transient changes at the env locus of
plasma human immunodeficiency virus type 1 populations during the emergence
of protease inhibitor resistance. (1998)
- K. M. Dobos, Emergence of a Unique Group of Necrotizing
Mycobacterial Diseases (1999)
- S. G. Deeks, HIV-1 Protease Inhibitors. A Review for
Clinicians (1997)
- E. L. Delwart, Genetic relationships determined by a DNA
heteroduplex mobility assay: analysis of HIV-1 env genes (1993)
- R. S. Diaz, Dual human immunodeficiency virus type 1
infection and recombination in a dually exposed transfusion recipient. The
Transfusion Safety Study Group (1995)
- R. S. Diaz, Lack of dual HIV infection in a transfusion
recipient exposed to two seropositive blood components (1996)
- E. L. Delwart, Human immunodeficiency virus type 1 evolution
in vivo tracked by DNA heteroduplex mobility assays (1994)
- G. Dodin, Fourier and wavelet transform analysis, a tool for
visualizing regular patterns in DNA sequences (2000)
- A. A. Ding, Relationships between antiviral treatment effects
and biphasic viral decay rates in modeling HIV dynamics (1999)
- A. A. Ding, A comparison study of models and fitting
procedures for biphasic viral dynamics in HIV-1 infected patients treated
with antiviral therapies. (2000)
- D. S. Dimitrov, Quantitation of Human Immunodeficiency Virus
Type 1 Infection Kinetics. (1993)
- H. L. Devereux, Rapid decline in detectability of HIV-1 drug
resistance mutations after stopping therapy. (1999)
- G. Dornadula, Residual HIV-1 RNA in blood plasma of patients
taking suppressive highly active antiretroviral therapy (1999)
- E
- J. W. Erickson, Structural mechanisms of HIV drug resistance
(1996)
- J. Eberle, Resistance of HIV type 1 to proteinase inhibitor
Ro 31-8959. (1995)
- B. Efron, Bootstrap Methods: Another Look at the Jackknife (1979)
- B. Efron, Nonparametric Estimates of Standard Eror: The
Jackknife, the Bootstrap and Other Methods (1981)
- B. Efron, Jacknife, Bootstrap (1982)
- B. Efron, Bootstrap Confidence Intervals for a Class of
Parametric Problems (1985)
- B. Efron, Better bootstrap confidence intervals (1987)
- J. W. Erickson, Protease inhibitors: resistance,
cross-resistance, fitness and the choice of initial and salvage therapies (1999)
- B. Efron, Bootstrap Confidence Levels for Phylogenetic Trees
(1996)
- B. Efron, Bootstrap confidence levels for phylogenetic trees
[corrected and republished in Proc Natl Acad Sci U S A 1996 Nov
12;93(23):13429-34] (1996)
- S. F. Elena, Test of synergistic interactions among
deleterious mutations in bacteria (1997)
- P. S. Eastman, Genotypic Changes in Human Immunodeficiency
Virus Type 1 Associated with Loss of Suppression of Plasma Viral RNA Levels
in Subjects Treated with Ritonavir (Norvir) Monotherapy. (1998)
- D. T. Evans, Virus-specific Cytotoxic T-lymphocyte responses
Select for Amino-acid Variation in Simian Immunodeficiency Virus Env and Nef
(1999)
- P. Essunger, Modeling HIV infection of CD4+ T-cell
subpopulations. (1994)
- S. M. Essajee, Early Changes in Quasispecies Repertoire in
HIV-Ifected Infants: Correlation with Disease Progression (2000)
- B. Efron, Boostrap Methods for Standard Errors, Confidence
Intervals, and Other Measures of Statistical Accuracy (1986)
- B. Efron, The Problem of Regions (1998)
- E. Evangelista, After living with HIV, living without
medication. (1999)
- J. Embretson, Analysis of Human Immunodeficiency
Virus-Infected Tissues by Amplification and in Situ Hybridization Reveals
Latent and Permissive Infections at Single-Cell Resolution. (1993)
- F
- A. S. Fauci, Host Factors and the Pathogenesis of HIV-Induced
Disease. (1996)
- D. Finzi, Latent Infection of CD4+ T Cells Provides a
Mechanism for Lifelong Persistence of HIV-1, Even in Patients on Effective
Combination therapy. (1999)
- M. R. Furtado, Persistence of HIV-1 Transcription in
Peripheral-Blood Mononuclear Cells in Patients Receiving Potent
Antiretroviral Therapy [see comments]. (1999)
- H. Fan, Virology and Human Immunodeficiency Virus. (1991)
- D. F. Feng, Progressive Sequence Alignment as a Prerequisite
to Correct Phylogenetic Trees (1987)
- N. M. Ferguson, Antigen-driven CD4+ T cell and HIV-1
dynamics: residual viral replication under highly active antiretroviral
therapy. (1999)
- J. Ferbas, Rapid evolution of human immunodeficiency virus
strains with increased replicative capacity during the seronegative window of
primary infection (1996)
- J. Felsenstein, Cases in which Parsimony or Compatibility
Methods will be Positively Misleading (1978)
- J. Felsenstein, Evolutionary Trees from DNA Sequences: a
Maximum Likelihood Approach. (1981)
- J. Felsenstein, Statistical Inference of Phylogenies (1983)
- J. Felsenstein, Confidence Limits on Phylogenies: An Approach
Using the Bootstrap (1985)
- J. Felsenstein, Phylogenies from molecular sequences:
inference and reliability (1988)
- D. H. A. Fitch, Phylogenetic Scanning: A Computer Assisted
Algorithm for Mapping Gene Conversions and Other Recombinational Events. (1991)
- E. J. Feil, Recombination within natural populations of
pathogenic bacteria: Short- term empirical estimates and long-term
phylogenetic consequences (2001)
- G. Fätkenheuer, Salvage Therapy With Regimens Containing
Ritonavir and Saquinavir in Extensively Pretreated HIV-Infected Patients (1999)
- D. Finzi, Identification of a Reservoir for HIV-1 in Patients
on Highly Active Antiretroviral Therapy [see comments]. (1997)
- K. Fukami-Kobayashi, Robustness of maximum likelihood tree
estimation against different patterns of base substitutions (1991)
- R. Fan, Models for haplotype evolution in a nonstationary
population (1998)
- S. D. Frost, Germinal Centre Destruction as a Major Pathway
of HIV Pathogenesis. (1994)
- S. D. Frost, Quasispecies Dynamics and the Emergence of Drug
Resistance During Zidovudine Therapy of HIV Infection. (1994)
- L. M. Frenkel, Genetic Evaluation of Suspected Cases of
Transient HIV-1 Infection of Infants. (1998)
- G
- M. Groenink, Phenotype-associated env gene variation among
eight related human immunodeficiency virus type 1 clones: evidence for in
vivo recombination and determinants of cytotropism outside the V3 domain (1992)
- M. J. Gibbs, Sister-scanning: a Monte Carlo procedure for
assessing signals in recombinant sequences (2000)
- M. J. Gibbs, Recombination in the Hemagglutinin Gene of the
1918 "Spanish Flu" (2001)
- M. J. Gibbs, The haemagglutinin gene, but not the
neuraminidase gene, of 'Spanish flu' was a recombinant (2001)
- C. G, An analysis of simultaneous variation in protein
structures (1997)
- J. E. Gallant, The Seropositive Patient - The Initial
Encounter (2000)
- N. Goldman, Likelihood-based tests of topologies in
phylogenetics (2000)
- S. Gavrilets, Rapid evolution of reproductive barriers driven
by sexual conflict (2000)
- B. G. Gazzard, Antiretroviral Treatment Guidelines in Britain
and the USA: Moving Closer? (2000)
- F. Gao, Origin of HIV-1 in the chimpanzee Pan troglodytes
troglodytes [see comments] (1999)
- J. Goudsmit, Human Immunodeficiency Virus Fitness in vivo:
Calculations Based on a Single Zidovudine Resistance Mutation at codon 215 of
Reverse Transcriptase. (1996)
- J. M. Guardiola, Switching HIV-1 Protease Inhibitor Therapy:
which? When? And why? [letter] (1999)
- Z. Grossman, HIV infection: how effective is drug combination
treatment? (1998)
- X. Gu, Maximum likelihood estimation of the heterogeneity of
substitution rate among nucleotide sites (1995)
- H. F. Günthard, Evolution of envelope sequences of human
immunodeficiency virus type 1 in cellular reservoirs in the setting of potent
antiviral therapy. (1999)
- H. F. Gunthard, Evolution of envelope sequences of human
immunodeficiency virus type 1 in cellular reservoirs in the setting of potent
antiviral therapy (1999)
- Z. Grossman, Multiple modes of cellular activation and virus
transmission in HIV infection: a role for chronically and latently infected
cells in sustaining viral replication (1998)
- Z. Gu, Possible involvement of cell fusion and viral
recombination in generation of human immunodeficiency virus variants that
display dual resistance to AZT and 3TC (1995)
- N. C. Grassly, A likelihood method for the detection of
selection and recombination using nucleotide sequences (1997)
- Z. Ghahramani, An Introduction to Hidden Markov Models and
Bayesian Networks (2001)
- N. C. Grassly, Population Dynamics of HIV-1 Inferred from
Gene Sequences (1999)
- D. Gilden, Absence makes the HAARt grow fonder (1999)
- P. M. Garcia, Maternal levels of plasma human
immunodeficiency virus type 1 RNA and the risk of perinatal transmission.
Women and Infants Transmission Study Group (1999)
- B. S. Gaut, Success of maximum likelihood phylogeny inference
in the four-taxon case (1995)
- H. F. Gunthard, Higher Selection Pressure from Antiretroviral
Drugs in Vivo Results in Increased Evolutionary Distance in HIV-1 Pol. (1999)
- M. J. Glesby, Intermittent HIV therapy (1999)
- F. D. Goebel, Recombinant gp160 as a therapeutic vaccine for
HIV-infection: results of a large randomized, controlled trial. European
Multinational IMMUNO AIDS Vaccine Study Group. (1999)
- F. Gao, Molecular cloning and analysis of functional envelope
genes from human immunodeficiency virus type 1 sequence subtypes A through G.
(1996)
- W. N. Grundy, Phylogenetic inference from conserved sites
alignments (1999)
- X. Gu, Locus specificity of polymorphic alleles and evolution
by a birth-and- death process in mammalian MHC genes (1999)
- N. Goldman, Statistical tests of models of DNA substitution
(1993)
- N. Goldman, Phylogenetic Information and Experimental Design
in Molecular Systematics (1998)
- Z. Grossman, Ongoing HIV dissemination during HAART. (1999)
- F. Garcia, The virological and immunological consequences of
structured treatment interruptions in chronic HIV-1 infection (2001)
- F. Garcia, Dynamics of Viral Load Rebound and Immunological
Changes After Stopping Effective Antiretroviral Therapy (1999)
- F. Gao, An isolate of human immunodeficiency virus type 1
originally classified as subtype I represents a complex mosaic comprising
three different group M subtypes (A, G, and I) (1998)
- F. Gao, A comprehensive panel of near-full-length clones and
reference sequences for non-subtype B isolates of human immunodeficiency
virus type 1. (1998)
- P. J. Green, Reversible jump markov chain monte carlo
computation and bayesian model determination (1995)
- F. Gao, The heterosexual human immunodeficiency virus type 1
epidemic in Thailand is caused by an intersubtype (A/E) recombinant of
African origin. (1996)
- S. V. Gulnik, Kinetic Characterization and Cross-Resistance
Patterns of HIV-1 Protease Mutants Selected Under Drug Pressure. (1995)
- X. Gu, Statistical methods for testing functional divergence
after gene duplication (1999)
- F. Garcia, Residual low-level viral replication could explain
discrepancies between viral load and CD4+ cell response in human
immunodeficiency virus-infected patients receiving antiretroviral therapy. (2000)
- H. F. Günthard, Human immunodeficiency virus replication and
genotypic resistance in blood and lymph nodes after a year of potent
antiretroviral therapy. (1998)
- H. F. Günthard, Effect of influenza vaccination on viral
replication and immune response in persons infected with human
immunodeficiency virus receiving potent antiretroviral therapy. (2000)
- N. Goldman, A codon-based model of nucleotide substitution
for protein-coding DNA sequences (1994)
- H
- P. R. Harrigan, Selection of Drug-Resistance HIV. (1999)
- T. E. Harris, The Theory of Branching Processes (1963)
- D. M. Hillis, An Empirical Test of Bootstrapping as a Method
for Assesing Confidence in Phylogenetic Analysis (1993)
- J. P. Huelsenbeck, A Likelihood Ratio Test to Detect
Conflicting Phylogenetic Signal (2000)
- I. Holmes, Evolutionary HMMs: a Bayesian approach to multiple
alignment (2001)
- A. V. Herz, Viral Dynamics in vivo: Limitations on Estimates
of Intracellular Delay and Virus Decay. (1996)
- S. M. Harrold, Tissue sites of persistent infection and
active replication of equine infectious anemia virus during acute disease and
asymptomatic infection in experimentally infected equids (2000)
- M. S. Hirsch, Antiretroviral drug resistance testing in
adults with HIV infection: implications for clinical management.
International AIDS Society-USA Panel [see comments]. (1998)
- S. A. Hammond, Maturation of the cellular and humoral immune
responses to persistent infection in horses by equine infectious anemia virus
is a complex and lengthy process (1997)
- S. B. Hedges, The Number of Replications Needed for Accurate
Estimation of the Bootstrap P Value in Phylogenetic Studies [letter] (1992)
- D. V. Havlir, Nevirapine-resistant human immunodeficiency
virus: kinetics of replication and estimated prevalence in untreated patients
(1996)
- J. Hein, Reconstructing evolution of sequences subject to
recombination using parsimony (1990)
- J. Hein, A Heuristic Method to Reconstruct the History of
Sequences Subject to Recombination (1993)
- R. M. Howell, In vivo sequence variation of the human
immunodeficiency virus type 1 env gene: evidence for recombination among
variants found in a single individual (1991)
- G. W. Hoffmann, When HIV Meets the Immune System: Network
Theory, Alloimmunity, Autoimmunity, and AIDS (1989)
- F. M. Hecht, Sexual transmission of an HIV-1 variant
resistant to multiple reverse- transcriptase and protease inhibitors [see
comments] (1998)
- R. E. Hill, Accelerated evolution in the reactive centre
regions of serine protease inhibitors (1987)
- J. P. Huelsenbeck, Success of Phylogenetic Methods in the
Four-taxon Case (1993)
- D. M. Hillis, Application and accuracy of molecular
phylogenies [see comments] (1994)
- M. Hellerstein, Directly measured kinetics of circulating T
lymphocytes in normal and HIV-1-infected humans. (1999)
- D. V. Havlir, Drug susceptibility in HIV infection after
viral rebound in patients receiving indinavir-containing regimens [see
comments] (2000)
- A. T. Haase, Quantitative Image Analysis of HIV-1 Infection
in Lymphoid Tissue. (1996)
- D. M. Hillis, Approaches for Assesing Phylogenetic Accuracy
(1995)
- M. D. Hughes, Monitoring Plasma HIV-1 RNA Levels in Addition
to CD4+ Lymphocyte Count Improves Assessment of Antiretroviral Therapeutic
Response. ACTG 241 Protocol Virology Substudy Team [see comments]. (1997)
- L. Heyndrickx, Simplified strategy for detection of
recombinant human immunodeficiency virus type 1 group M isolates by gag/env
heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in
African Cities (2000)
- R. R. Hudson, Statistical properties of the number of
recombination events in the history of a sample of DNA sequences (1985)
- R. R. Hudson, The coalescent process in models with selection
and recombination (1988)
- M. Hasegawa, Confidence Limits on the Maximum Likelihood
Estimate of the Hominoid Tree from Mitochondrial-DNA Sequences (1989)
- M. Hasegawa, Accuracies of the Simple Methods for Estimating
the Bootstrap Probability of a Maximum-Likelihood Tree (1994)
- R. D. Hockett, Constant Mean Viral Copy Number per Infected
Cell in Tissues Regardless of High, Low, or Undetectable Plasma HIV RNA. (1999)
- A. Hubner, Fidelity of Human Immunodeficiency Virus Type I
Reverse Transcriptase in Copying Natural RNA (1992)
- M. Hasegawa, On the maximum likelihood method in molecular
phylogenetics [comment] (1991)
- M. Hasegawa, Dating of the human-ape splitting by a molecular
clock of mitochondrial DNA (1985)
- S. A. Hammond, Immune responses and viral replication in
long-term inapparent carrier ponies inoculated with equine infectious anemia
virus (2000)
- D. M. Hillis, An Overview of Applications of Molecular
Systematics. (1990)
- D. V. Havlir, Maintenance antiretroviral therapies in HIV
infected patients with undetectable plasma HIV RNA after triple-drug therapy.
AIDS Clinical Trials Group Study 343 Team [see comments]. (1998)
- A. L. Hughes, Pattern of nucleotide substitution at major
histocompatibility complex class I loci reveals overdominant selection (1988)
- D. D. Ho, Rapid Turnover of Plasma Virions and CD4
Lymphocytes in HIV-1 Infection. (1995)
- P. A. Haslett, Strong human immunodeficiency virus
(HIV)-specific CD4+ T cell responses in a cohort of chronically infected
patients are associated with interruptions in anti-HIV chemotherapy (2000)
- D. D. Ho, HIV-1 Dynamics in Vivo. (1995)
- D. D. Ho, Time to Hit HIV, Early and Hard (1995)
- B. Hirschel, The Year in Review: Antiretroviral Treatment (1999)
- M. D. Hazenberg, Increased cell division but not thymic
dysfunction rapidly affects the T-cell receptor excision circle content of
the naive T cell population in HIV-1 infection (2000)
- D. C. Horter, Characterization of the carrier state in
porcine reproductive and respiratory syndrome virus infection (2002)
- B. F. Haynes, Toward an Understanding of the Correlates of
Protective Immunity to HIV Infection (1996)
- E. C. Holmes, The Molecular Population Dynamics of HIV-1 (2000)
- D. D. Ho, Pathogenesis of Infection with Human
Immunodeficiency Virus. (1987)
- T. M. Howard, Genomic Structure and Nucleotide Sequence
Analysis of a New HIV Type 1 Subtype A Strain from Nigeria. (1996)
- J. P. Huelsenbeck, Phylogenetic Methods Come of Age: Testing
Hypotheses in an Evolutionary Context (1997)
- J. Hughes, Estimation of the Joint Distribution of Infection
and Death for Vertical Transmission of HIV-1 (1999)
- J. P. Huelsenbeck, A Bayesian framework for the analysis of
cospeciation (2000)
- A. Holguin, Recombinant human immunodeficiency viruses type 1
circulating in Spain (2000)
- W. S. Hu, Genetic consequences of packaging two RNA genomes
in one retroviral particle: pseudodiploidy and high rate of genetic
recombination (1990)
- W. S. Hu, Retroviral recombination and reverse transcription
(1990)
- W. S. Hu, Effect of gamma radiation on retroviral
recombination (1992)
- R. R. Hudson, Properties of a neutral allele model with
intragenic recombination (1983)
- J. P. Huelsenbeck, Performance of Phylogenetic Methods in
Simulation (1995)
- J. P. Huelsenbeck, The robustness of two phylogenetic
methods: four-taxon simulations reveal a slight superiority of maximum
likelihood over neighbor joining (1995)
- E. C. Holmes, The influence of recombination on the
population structure and evolution of the human pathogen Neisseria
meningitidis (1999)
- D. H. Huson, SplitsTree: analyzing and visualizing
evolutionary data (1998)
- J. Hey, A coalescent estimator of the population
recombination rate (1997)
- P. R. Harrigan, Rate of HIV-1 RNA Rebound Upon Stopping
Antiretroviral Therapy. (1999)
- E. C. Holmes, Phylogenetic evidence for recombination in
dengue virus (1999)
- D. D. Ho, HIV-1 rebound after anti-retroviral therapy [news;
comment] (2000)
- I
- J
- F. J, Taking variation of evolutionary rates between sites
into account in inferring phylogenies (2001)
- U. Junker, Antiviral Potency of Drug-Gene Therapy
Combinations Against Human Immunodeficiency Virus Type 1. (1997)
- V. Jubault, High Rebound of Plasma and Cellular HIV Load
After Discontinuation of Triple Combination Therapy [letter]. (1998)
- T. H. Jukes (1969)
- I. B. Jakobsen, A program for calculating and displaying
compatibility matrices as an aid in determining reticulate evolution in
molecular sequences (1996)
- T. O. Jonassen, Intersubtype recombinant HIV type 1 involving
HIV-MAL-like and subtype H-like sequence in four Norwegian cases (2000)
- W. Janssens, Genetic and Phylogenetic Analysis of env
Subtypes G and H in Central Africa (1994)
- M. J. Jin, Mosaic genome structure of simian immunodeficiency
virus from west African green monkeys (1994)
- J. Ji, Fidelity of HIV-1 Reverse Transcriptase Copying a
Hypervariable region of the HIV-1 env gene (1994)
- V. Jubier-Maurin, Genetic characterization of the nef gene
from human immunodeficiency virus type 1 group M strains representing genetic
subtypes A, B, C, E, F, G, and H (1999)
- L. Jin, Limitations of the evolutionary parsimony method of
phylogenetic analysis [published erratum appears in Mol Biol Evol 1990
Mar;7(2):201] (1990)
- M.-P. J, Selection of antiretroviral resistance in the latent
reservoir of human immunodeficiency virus type 1 during successful therapy.
(2000)
- H. Jonckheere, Lamivudine Resistance of HIV Type 1 Does not
Delay Development of Resistance to Nonnucleoside HIV Type 1-Specific Reverse
Transcriptase Inhibitors as Compared With Wild-Type HIV Type 1. (1998)
- I. B. Jakobsen, The partition matrix: exploring variable
phylogenetic signals along nucleotide sequence alignments (1997)
- A. E. Jetzt, High rate of recombination throughout the human
immunodeficiency virus type 1 genome (2000)
- K
- L. G. Kostrikis, Genetic analysis of human immunodeficiency
virus type 1 strains from patients in Cyprus: identification of a new subtype
designated subtype I (1995)
- M. K. Kuhner, Usefulness of single nucleotide polymorphism
data for estimating population parameters (2000)
- K. Kusumi, Human Immunodeficiency Virus Type 1 Envelope Gene
Structure and Diversity In Vivo and after Cocultivation in Vitro (1992)
- G. R. Kaufmann, Patterns of viral dynamics during primary
human immunodeficiency virus type 1 infection. The Sydney Primary HIV
Infection Study Group. (1998)
- J. K. Kelly, An Application of Population Genetic Theory to
Synonymous Gene Sequence Evolution in the Human Immunodeficiency Virus (HIV)
(1994)
- T. B. Kepler, Codon Bias and Plasticity in Immunoglobulins (1997)
- M. K. Kuhner, A simulation comparison of phylogeny algorithms
under equal and unequal evolutionary rates [published erratum appears in Mol
Biol Evol 1995 May;12(3):525] (1994)
- C. L. Kuiken, Determinants of HIV-1 Protein Evolution (2000)
- J. M. Koshi, Probabilistic reconstruction of ancestral
protein sequences (1996)
- S. Koenig, Detection of AIDS virus in macrophages in brain
tissue from AIDS patients with encephalopathy. (1986)
- H. Kishino, Evaluation of the maximum likelihood estimate of
the evolutionary tree topologies from DNA sequence data, and the branching
order in hominoidea (1989)
- M. Kimura, A Simple Method for Estimating Evolutionary Rates
of Base Substitutions Through Comparative Studies of Nucleotide Sequences (1980)
- J. Kingman, Poisson Processes (1993)
- F. A. Kondrashov, Multidimensional epistasis and the
disadvantage of sex (2001)
- B. Korber, A Compilation and Analysis of Nucleic Acid and
Amino Acid Sequences. (1998)
- B. T. M. Korber, Genetic Differences between Blood- and
Brain-Derived Viral Sequences from Human Immunodeficiency Virus Type
1-Infected Patients: Evidence of Conserved Protein of Brain-Derived Sequences
(1994)
- P. Kellam, Retroviral recombination can lead to linkage of
reverse transcriptase mutations that confer increased zidovudine resistance.
(1995)
- M. K. Kuhner, Gene conversion in the evolution of the human
and chimpanzee MHC class I loci (1991)
- A. D. Kelleher, Clustered mutations in HIV-1 gag are
consistently required for escape from HLA-B27-restricted cytotoxic T
lymphocyte responses (2001)
- D. E. Kirschner, Optimal Control of the Chemotherapy of HIV.
(1997)
- H. Kishino, Maximum Likelihood Inference of Protein Phylogeny
and the Origin of Chloroplasts (1990)
- T. Kuwata, The rapid spread of recombinants during a natural
in vitro infection with two human immunodeficiency virus type 1 strains (1997)
- D. E. Kirschner, The Role of Thyumus in Pediatric HIV-1
Infection. (1998)
- B. T. M. Korber, Mutational Trends in V3 Loop Protein
Sequences Observed in Different Genetic Lineages of Human Immunodeficiency
Virus Type 1 (1994)
- A. Kamina, A Stochastic Modeling of Early HIV-1 Population
Dynamics (2001)
- B. D. Korant, Inhibitor-Resistant Mutants of the HIV-1
Aspartic Protease. (1995)
- D. E. Kirschner, Mathematical Population Dynamics III, Theory
of Epidemics (1994)
- T. B. Kepler, Drug Concentration Heterogeneity Facilitates
the Evolution of Drug Resistance. (1998)
- P. Krogstad, Year 2 Progress Report: Elizabeth Glaser
Scientist Award 16-00 (2000)
- B. F. Koop, Tarsius Delta- and Beta-Globin Genes:
Conversions, Evolution, and Systematic Implications (1989)
- G. A. Kampinga, Primary Infections with HIV-1 of Women and
their Offspring in Rwanda: Findings of Heterogeneity at Seroconversion,
Coinfection, and Recombinants of HIV-1 Subtypes A and C (1997)
- P. Krogstad, Primary HIV infection of infants: the effects of
somatic growth on lymphocyte and virus dynamics (1999)
- P. Krogstad, Primary HIV infection of infants: the effects of
somatic growth on lymphocyte and virus dynamics [see comments] (1999)
- D. Kuritzkes, Progress in HIV Pathogenesis, Drug Resistance
and Drug Development (1999)
- D. R. Kuritzkes, HIV/AIDS Clinical Management Volume 2 - HIV
Pathogenesis and Viral Markers (2000)
- D. E. Kirschner, A Model for Treatment Strategy in the
Chemotherapy of AIDS. (1996)
- D. E. Kirschner, Effects of Drug Resistance on Monotherapy
Treatment of HIV Infection. (1996)
- D. E. Kirschner, A Mathematical Model of Combined Drug
Therapy of HIV Infection. (1997)
- D. E. Kirschner, Resistance, Remission, and Qualitative
Differences in HIV Chemotherapy. (1997)
- D. E. Kirschner, Understanding Drug Resistance for
Monotherapy Treatment of HIV Infection. (1997)
- M. J. Keeling, Dynamics of the 2001 UK foot and mouth
epidemic: stochastic dispersal in a heterogeneous landscape (2001)
- M. K. Kuhner, Estimating effective population size and
mutation rate from sequence data using Metropolis-Hastings sampling (1995)
- M. K. Kuhner, Maximum likelihood estimation of population
growth rates based on coalescent (1998)
- M. K. Kuhner, Maximum likelihood estimation of recombination
rates from population data (2000)
- A. Kamina, HIV-1 Specific Immune Response on Growth of Drugs
Resistant Mutants during Antiviral Drug Treatment (2000)
- L
- T. Leitner, The molecular clock of HIV-1 unveiled through
analysis of a known transmission history (1999)
- B. R. Levin, Resistance to Antimicrobial Chemotherapy: a
Prescription for Research and Action. (1998)
- J. A. Lake, Reconstructing evolutionary trees from DNA and
protein sequences: paralinear distances (1994)
- J. A. Lake, Calculating the probability of multitaxon
evolutionary trees: bootstrappers Gambit (1995)
- T. Laukkanen, Virtually full-length sequences of HIV type 1
subtype J reference strains (1999)
- K. Lange, Calculation of the equilibrium distribution for a
deleterious gene by the finite Fourier transform (1982)
- J. M. Lange, Triple combinations: present and future. (1995)
- L. Lands, Drug holidaze - Sean's short-term vacation may
endanger long-term viral suppression. (1999)
- A. J. Leigh Brown, Analysis of HIV-1 env gene sequences
reveals evidence for a low effective number in the viral population. (1997)
- K. S. Lole, Full-Length Human Immunodeficiency Virus Type 1
Genomes from Subtype C-Infected Seroconverters in India, with Evidence of
Intersubtype Recombination (1999)
- A. J. Leigh Brown, HIV-1: Gambling on the evolution of drug
resistance? (1997)
- T. Laukkanen, Virtually full-length subtype F and F/D
recombinant HIV-1 from Africa and South America (2000)
- M. M. Lederman, Immunologic responses associated with 12
weeks of combination antiretroviral therapy consisting of zidovudine,
lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol
315. (1998)
- G. M. Lucas, Highly Active Antiretroviral Therapy in a Large
Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions
(1999)
- S. J. Little, Reduced antiretroviral drug susceptibility
among patients with primary HIV infection [see comments] (1999)
- T. Lumley, The importance of the normality assumption in
large public health data sets (2002)
- T. Leitner, Accurate reconstruction of a known HIV-1
transmission history by phylogenetic tree analysis (1996)
- T. Leitner, Biological and Molecular Characterization of
Subtype D, G, and A/D Recombinant HIV-1 Transmissions in Sweden (1995)
- J. Levin, Interrupting HAART; Hydroxyurea; Five+ Drug Therapy
- Report from the RIGHT Conference (1999)
- K. Lange, Branching process models for mutant genes in
nonstationary populations (1997)
- E. Lorenzo, The Tat and C2-V3 envelope genes in the molecular
epidemiology of human immunodeficiency virus-1 (1996)
- V. V. Lukashov, Circulation of subtype A and gagA/envB
recombinant HIV type 1 strains among injecting drug users in St. Petersburg,
Russia, correlates with geographical origin of infections. (1999)
- W. H. Li, Unbiased estimation of the rates of synonymous and
nonsynonymous substitution [letter] (1993)
- C. Leroux, Novel and dynamic evolution of equine infectious
anemia virus genomic quasispecies associated with sequential disease cycles
in an experimentally infected pony (1997)
- Y. Li, Molecular characterization of human immunodeficiency
virus type 1 cloned directly from uncultured human brain tissue:
identification of replication-competent and -defective viral genomes (1991)
- A. L. Landay, Impact of protease inhibitors on the management
of HIV infection (1999)
- C. Loveday, HIV-1 RNA Serum-Load and Resistant Viral
Genotypes During Early Zidovudine Therapy. (1995)
- O. Lund, Gene Therapy of T Helper Cells in HIV Infection:
Mathematical Model of the Criteria for Clinical Effect (1997)
- F. Lori, Control of SIV rebound through structured treatment
interruptions during early infection (2000)
- B. r. o. w. n. Leigh, Evolution of the Structural Proteins of
Human Immunodeficiency Virus: Selective Constraints on Nucleotide
Substitution (1988)
- S. P. Layne, Factors underlying spontaneous inactivation and
susceptibility to neutralization of human immunodeficiency virus. (1992)
- E. M. Long, Gender Differences in HIV-1 Diversity at Time of
Infection (2000)
- J. Louwagie, Phylogenetic analysis of gag genes from 70
international HIV-1 isolates provides evidence for multiple genotypes (1993)
- S. P. Layne, Blocking of human immunodeficiency virus
infection depends on cell density and viral stock age. (1991)
- S. J. Little, Viral dynamics of acute HIV-1 infection. (1999)
- P. Lorenzi, Impact of Drug Resistance Mutations on Virologic
Response to Salvage Therapy. Swiss HIV Cohort Study. (1999)
- J. C. Long, The Allelic Correlation Structure of Gainj- and
Kalam-speaking people. I. The Estimation and Interpretation of Wright's
F-statistics (1986)
- F. Lori, Hydroxyurea and HIV: 5 years later-from antiviral
to immune-modulating effects [editorial]. (1999)
- B. T. Lahn, Four Evolutionary Strata on the Human X
Chromosome (1999)
- S. Li, Phylogenetic Tree Construction Using Markov Chain
Monte Carlo (2000)
- B. T. Lahn, The human Y chromosome, in the light of evolution
(2001)
- B. e. L, High levels of drug-resistant human immunodeficiency
virus variants in patients exhibiting increasing CD4+ T cell counts despite
virologic failure of protease inhibitor-containing antiretroviral combination
therapy (2000)
- K. Lange, Disease Gene Dynamics in a Population Isolate (2000)
- J. Lisziewicz, Control of HIV Despite the Discontinuation of
Antiretroviral Therapy (1999)
- B. Larget, Markov chain monte carlo algorithms for the
bayesian analysis of phylogenetic trees (1999)
- P. O. Lewis, Back to the future: Bayesian inference arrives
in phylogenetics (2001)
- S. P. Layne, Quantifying the infectivity of human
immunodeficiency virus. (1989)
- J. Lawrence, Clinical resistance patterns and responses to
two sequential protease inhibitor regimens in saquinavir and reverse
transcriptase inhibitor-experienced persons. (1999)
- K. Liitsola, HIV-1 genetic subtype A/B recombinant strain
causing an explosive epidemic in injecting drug users in Kaliningrad (1998)
- W. H. Li, Rates and Dates of Divergence Between AIDS Virus
Nucleotide Sequences (1988)
- J. Lyons-Weiler, Escaping from the Felsenstein zone by
detecting long branches in phylogenetic data (1997)
- J. Lyons-Weiler, Relative apparent synapomorphy analysis
(RASA). I: The statistical measurement of phylogenetic signal (1996)
- W. H. Li, A new method for estimating synonymous and
nonsynonymous rates of nucleotide substitution considering the relative
likelihood of nucleotide and codon changes (1985)
- W. J. Lech, In vivo sequence diversity of the protease of
human immunodeficiency virus type 1: presence of protease inhibitor-resistant
variants in untreated subjects (1996)
- W. J. Lech, In vivo sequence diversity of the protease of
human immunodeficiency virus type 1: presence of protease inhibitor-resistant
variants in untreated subjects (1996)
- P. Lorenzi, Toxicity, efficacy, plasma drug concentrations
and protease mutations in patients with advanced HIV infection treated with
ritonavir plus saquinavir. Swiss HIV Cohort Study (1997)
- W. H. Li, Statistical Tests of DNA Phylogenies (1995)
- S. M. Lonning, Gag protein epitopes recognized by CD4(+)
T-helper lymphocytes from equine infectious anemia virus-infected carrier
horses (1999)
- M
- B. M., Can Immune Systems Be Trained to Fight HIV? (1999)
- M. J. Mackinnon, Survival probability of drug resistant
mutants in malaria parasites [published erratum appears in Proc R Soc Lond B
Biol Sci 1997 Dec 22;264(1389):1849] (1997)
- L. M. Mansky, Forward mutation rate of human immunodeficiency
virus type 1 in a T lymphoid cell line (1996)
- I. C. Marschner, Design of HIV Viral Dynamics Studies (1998)
- A. P. Martin, Increasing genomic complexity by gene
duplication and the origin of Vertebrates (1999)
- D. L. Mayers, Prevalence and incidence of resistance to
zidovudine and other antiretroviral drugs. (1997)
- F. E. McCutchan, Subtype G and multiple forms of A/G
intersubtype recombinant human immunodeficiency virus type 1 in Nigeria (1999)
- I. C. Marschner, Use of Changes in Plasma Levels of Human
immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of
Antiretroviral Therapy. (1998)
- E. Montgomery, A test for the role of natural selection in
the stabilization of transposable element copy number in a population of
Drosophila melanogaster (1987)
- L. Moutouh, Recombination leads to the rapid emergence of
HIV-1 dually resistant mutants under selective drug pressure (1996)
- F. N. M, The foot-and-mouth epidemic in Great Britain:
pattern of spread and impact of interventions (2001)
- T. Massingham, Analysing gene function after duplication (2001)
- W. J. Murphy, Resolution of the early placental mammal
radiation using Bayesian phylogenetics (2001)
- S. J. Merrill, Background and Dynamics of the decline of
immunocompetence (1988)
- S. J. Merrill, Modeling the interaction of HIV with cells of
the immune system. (1989)
- A. R. McLean, Population dynamics of HIV within an individual
after treatment with zidovudine. (1991)
- J. Mittler, Short-term measures of relative efficacy predict
longer-term reductions in human immunodeficiency virus type 1 RNA levels
following nelfinavir monotherapy (2001)
- A. R. McLean, Zidovudine and HIV: matehmatical models of
within-host population dynamics. (1995)
- S. V. Muse, A likelihood approach for comparing synonymous
and nonsynonymous nucleotide substitution rates, with application to the
chloroplast genome (1994)
- G. J. Moyle, Antiretroviral Therapy for HIV Infection. A
Knowledge-based Approach to Drug Selection and Use (1998)
- A. Mocroft, Predictors of a viral response and subsequent
virological treatment failure in patients with HIV starting a protease
inhibitor. (1998)
- L. H. Monteiro, A condition for successful escape of a mutant
after primary HIV infection (2000)
- J. S. G. Montaner, Rebound of plasma HIV viral load following
prolonged suppression with combination therapy. (1998)
- C. Michelet, [Discontinuation of antiretroviral treatment
containing a protease inhibitor. Failure and tolerance]. (1999)
- E. N. Moriyama, Mutation pattern of human immunodeficiency
virus gene (1991)
- V. Miller, Structured treatment interruptions in
antiretroviral management of HIV- 1 (2001)
- J. E. Mittler, Presentation: Dynamics in viral turnover in
HIV disease (1997)
- G. J. Mitchison, A probabilistic treatment of phylogeny and
sequence alignment (1999)
- R. T. Mitsuyasu, The role of immunotherapy in the treatment
of HIV (1999)
- R. T. Mitsuyasu, The Role of Immunotherapy in the Treatment
of HIV (1999)
- J. Mittler, Dynamics of Viral Turnover in HIV Disease (2000)
- A. R. McLean, A model of human immunodeficiency virus
infection in T helper cell clones. (1990)
- A. Molla, Ordered accumulation of mutations in HIV protease
confers resistance to ritonavir (1996)
- G. Myers, Human Retroviruses and AIDS 1995: A Compilation and
Analysis of Nucleic Acid and Amino Acid Sequences (1995)
- J. M. Murray, A model of primary HIV-1 infection. (1998)
- J. E. Mittler, T-cell Homeostasis, Competition, and Drift:
AIDS as HIV-Accelerated Senescence of the Immune Repertoire (1996)
- S. Marquina, Coexistence of subtypes B, F, and as B/F env
recombinant of HIV type 1 in Buenos Aires Argentina. (1996)
- J. A. McKeating, HIV Infectivity (1991)
- A. R. McLean, In Vivo estimates of division and death rates
of human T lymphocytes (1995)
- C. A. Michie, Lifespan of human lymphocyte subsets defined by
CD45 isoforms (1992)
- A. Morris, Mosaic structure of the human immunodeficiency
virus type 1 genome infecting lymphoid cells and the brain: evidence for
frequent in vivo recombination events in the evolution of regional
populations (1999)
- J. E. Mittler, Improved estimates for H1V-1 clearance rate
and intracellular delay. (1999)
- J. A. McKeating, Differential loss of envelope glycoprotein
gp120 from virions of human immunodeficiency virus type 1 isolates: effects
on infectivity and neutralization (1991)
- F. Martinon, Persistent Alterations in T-cell Repertoire,
Cytokine and Chemokine Receptor Gene Expression After 1 year of Highly Active
Antiretroviral Therapy (1999)
- A. R. McLean, Competition Between Zidovudine-Sensitive and
Zidovudine-Resistant Strains of HIV (1992)
- A. R. McLean, Models of interactions between HIV and other
pathogens. (1992)
- R. M. May, Superinfection, metapopulation dynamics, and the
evolution of diversity (1994)
- D. M. Mwaengo, Molecular cloning and characterization of
viruses isolated from chimpanzees with pathogenic human immunodeficiency
virus type 1 infections (1998)
- B. Mau, Bayesian phylogenetic inference via Markov chain
Monte Carlo methods (1999)
- L. J. Montaner, Structured treatment interruptions to control
HIV-1 and limit drug exposure (2001)
- V. Morozov, Homologous recombination between different
genotypes of hepatitis B virus (2000)
- W. Maury, Localized sequence heterogeneity in the long
terminal repeats of in vivo isolates of equine infectious anemia virus (1997)
- J. Martinez-Picado, Replicative Fitness of Protease
Inhibitor-resistant Mutants of Human Immunodeficiency Virus Type 1. (1999)
- C. D. Morrow, Viral gene products and replication of the
human immunodeficiency type 1 virus (1994)
- Mitsuyasu, HIV/AIDS Treatment Updates - Immunotherapy in the
Treatment of HIV (1999)
- D. Melnick, Impact of Phenotypic Antiretroviral Drug
Resistance Testing on the Response to Salvage Antiretroviral Therapy (ART) in
Heavily Experienced Patients (2000)
- P. Moreno, Alveolar macrophages are not an important source
of viral production in HIV-1 infected patients [letter]. (1996)
- W. Messier, Episodic adaptive evolution of primate lysozymes
(1997)
- J. Mallatt, 28S and 18S rDNA sequences support the monophyly
of lampreys and hagfishes (1998)
- F. E. McCutchan, HIV-1 genetic diversity. (1996)
- J. E. Mittler, Influence of Delayed Viral Production on Viral
Dynamics in HIV-1 Infected Patients. (1998)
- J. Maynard Smith, Detecting recombination from gene trees (1998)
- M. A. Martinez, Reverse transcriptase and substrate
dependence of the RNA hypermutagenesis reaction (1995)
- L. M. Mansky, Lower in vivo mutation rate of human
immunodeficiency virus type 1 than that predicted from the fidelity of
purified reverse transcriptase (1995)
- L. M. Mansky, Lower in vivo mutation rate of human
immunodeficiency virus type 1 than that predicted from the fidelity of
purified reverse transcriptase (1995)
- M. Markowitz, The effect of commencing combination
antiretroviral therapy soon after human immunodeficiency virus type 1
infection on viral replication and antiviral immune responses. (1999)
- A. Meyerhans, DNA recombination during PCR (1990)
- J. Mallat, Testing the New Animal Phylogeny: First Use of
Combined Large-Subunit and Small-Subunit rRNA Gene Sequences to Classify the
Protostomes (2002)
- G. McGuire, A graphical method for detecting recombination in
phylogenetic data sets (1997)
- T. Miyata, Molecular evolution of mRNA: a method for
estimating evolutionary rates of synonymous and amino acid substitutions from
homologous nucleotide sequences and its application (1980)
- N
- G. N, Maximum-likelihood phylogenetic analysis under a
covarion-like model (2001)
- M. A. Nowak, HIV-1 evolution and disease progression. (1996)
- J. P. Nadler, Challenges of the Acute Retroviral Syndrome. (1999)
- M. A. Nowak, Antigenic diversity thresholds and the
development of AIDS. (1991)
- M. A. Nowak, Population dynamics of immune responses to
persistent viruses. (1996)
- M. Negroni, Copy-choice recombination by reverse
transcriptases: reshuffling of genetic markers mediated by RNA chaperones (2000)
- M. A. Nowak, Viral dynamics in hepatitis B virus infection.
(1996)
- M. A. Nowak, HIV Results in the Frame. Results confirmed
[letter; comment]. (1995)
- M. Nijhuis, Stochastic Processes Strongly Influence HIV-1
Evolution During Suboptimal Protease-Inhibitor Therapy (1998)
- M. A. Nowak, Anti-viral Drug Treatment: Dynamics of
Resistance in Free Virus and Infected Cell Populations. (1997)
- W. C. Navidi, Methods for inferring phylogenies from nucleic
acid sequence data by using maximum likelihood and linear invariants (1991)
- W. C. Navidi, Methods for inferring phylogenies from nucleic
acid sequence data by using maximum likelihood and linear invariants (1991)
- W. C. Navidi, Phylogenetic inference: linear invariants and
maximum likelihoo (1993)
- D. Nettleton, Testing the Equality of Distributions of Random
Vectors with Categorical Components (2001)
- M. Newton, Bootstrapping Phylogenies - Large Deviations and
Dispersion Effects (1996)
- G. N, Detecting bottlenecks and selective sweeps from DNA
sequence polymorphism (2000)
- M. Nei, Simple methods for estimating the numbers of
synonymous and nonsynonymous nucleotide substitutions (1986)
- D. W. Notermans, Rate of HIV-1 decline following
antiretroviral therapy is related to viral load at baseline and drug regimen.
(1998)
- P. L. Nara, Neutralization of HIV-1: A Paradox of Humoral
Proportions. (1991)
- M. Nei, Evolution by the birth-and-death process in multigene
families of the vertebrate immune system (1997)
- I. Najera, Pol gene quasispecies of human immunodeficiency
virus: mutations associated with drug resistance in virus from patients
undergoing no drug therapy (1995)
- J. R. Neilson, Subtypes of human immunodeficiency virus type
1 and disease stage among women in Nairobi, Kenya (1999)
- A. U. Neumann, Hepatitis C viral dynamics in vivo and the
antiviral efficacy of interferon-alpha therapy (1998)
- M. A. Nowak, Mathematical biology of HIV infections:
antigenic variation and diversity threshold. (1991)
- M. A. Nowak, A mathematical model of vaccination against HIV
to prevent the development of AIDS (1991)
- M. A. Nowak, Coexistence and Competition in HIV Infections.
(1992)
- M. A. Nowak, How HIV Defeats the Immune System (1995)
- G. J. P. Naylor, Amphioxus Mitochondrial DNA, Chordate
Phylogeny, and the Limits of Inference Based on Comparisons of Sequences (1998)
- M. A. Nowak, The Evolutionary Dynamics of HIV-1 Quasispecies
and the Development of Immunodeficiency Disease. (1990)
- M. A. Nowak, Antigenic oscillations and shifting
immunodominance in HIV-1 infections [see comments]. (1995)
- D. Normile, Impact of DNA Replication Errors Put to the Test
(1996)
- M. A. Nowak, Variability of HIV infections (1992)
- G. Nasioulas, Molecular analysis of the full-length genome of
HIV type 1 subtype I: evidence of A/G/I recombination (1999)
- M. Negroni, Homologous recombination promoted by reverse
transcriptase during copying of two distinct RNA templates (1995)
- T. Nguyen, A Derivation of All Linear Invariants for a
Nonbalanced Transversion Model (1992)
- M. Nijhuis, Lamivudine-resistant human immunodeficiency virus
type 1 variants (184V) require multiple amino acid changes to become
co-resistant to zidovudine in vivo. (1997)
- A. U. Neumann, HIV-1 rebound during interruption of highly
active antiretroviral therapy has no deleterious effect on reinitiated
treatment. Comet Study Group (1999)
- S. B. Needleman, A General Method Applicable to the Search
for Similiarities in the Amino Acid Sequence of Two Proteins (1970)
- R. Nielsen, Likelihood models for detecting positively
selected amino acid sites and applications to the HIV-1 envelope gene (1998)
- O
- P
- H. J. P, Testing a covariotide model of DNA substitution (2002)
- D. Posada, Evaluation of methods for detecting recombination
from DNA sequences: Computer simulations (2001)
- A. Prugel-Bennett, Modelling Evolving Populations (1997)
- H. J. P, Accommodating phylogenetic uncertainty in
evolutionary studies (2000)
- D. Posada, MODELTEST: testing the model of DNA substitution
(1998)
- M. Patel, Primate DAX1, SRY, and SOX9: Evolutionary
Stratification of Sex-Determination Pathway (2001)
- W. R. Pearson, Searching Protein Sequence Libraries:
Comparison of the Sensitivity and Selectivity of the Smith-Waterman and FASTA
Algorithms. (1991)
- A. S. Perelson, Decay Characteristics of HIV-1-Infected
Compartments During Combination Therapy. (1997)
- A. S. Perelson, Modeling the Interaction of the Immune System
with HIV (1989)
- A. S. Perelson, Two theoretical problems in immunology: AIDS
and epitopes in complexity: metaphors, models, and reality (1994)
- M. Peeters, Predominance of subtype A and G HIV type 1 in
Nigeria, with geographical differences in their distribution (2000)
- S. C. Peters, Balm for Bootstrap Confidence Intervals (1987)
- H. J. P, MRBAYES: Bayesian inference of phylogenetic trees (2001)
- H. J. P, Bayesian inference of phylogeny and its impact on
evolutionary biology (2002)
- Pantaleo, New Concepts in the Immunopathogenesis of HIV
Infection (1995)
- L. Piroth, [Discontinuing protease inhibitor treatment of
HIV-1 patients for intolerance. Longitudinal study of 309 patients]. (1999)
- H. M. Precious, Multiple sites in HIV-1 reverse transcriptase
associated with virological response to combination therapy. (2000)
- A. N. Phillips, Reduction of HIV Concentration During Acute
Infection: Independence from a Specific Immune Response. (1998)
- I. Pellegrin, Emergence of zidovudine and
multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in
therapy-naive patients receiving stavudine plus didanosine combination
therapy. STADI Group. (1999)
- S. C. Piscitelli, The Limited Value of Therapeutic Drug
Monitoring in HIV Infection. (1999)
- A. S. Perelson, Dynamics of HIV Infection of CD4+ T Cells. (1993)
- N. G. Pakker, Immune restoration does not invariably occur
following long-term HIV-1 suppression during antiretroviral therapy. INCAS
Study Group. (1999)
- H. Pang, Genetic variation of envelope gp90 gene of equine
infectious anemia virus isolated from an experimentally infected horse (1997)
- N. T. Parkin, Phenotypic changes in drug susceptibility
associated with failure of human immunodeficiency virus type 1 (HIV-1) triple
combination therapy. (1999)
- A. N. Phillips, HIV Suppression and Risk of Drug Rresistance
Mutations. (1998)
- M. Peeters, Characterization of a highly replicative
intergroup M/O human immunodeficiency virus type 1 recombinant isolated from
a Cameroonian patient (1999)
- S. Pilyugin, Modeling T-cell proliferation: an investigation
of the consequences of the Hayflick limit. (1997)
- C. D. Pilcher, Detectable HIV-1 RNA at Levels Below
Quantifiable Limits by Amplicor HIV-1 Monitor is Associated with Virologic
Relapse on Antiretroviral Therapy (1999)
- A. N. Phillips, HIV-1 Dynamics After Transient Antiretroviral
Therapy: Implications for Pathogenesis and Clinical Management (1997)
- A. N. Phillips, In vivo HIV-1 replicative capacity in early
and advanced infection (1999)
- P. Pineau, Extensive analysis of duplicated-inverted
hepatitis B virus integrations in human hepatocellular carcinoma (1998)
- T. Pierson, Reservoirs for HIV-1: mechanisms for viral
persistence in the presence of antiviral immune responses and antiretroviral
therapy (2000)
- M. Pellegrini, Assigning Protein Functions by Comparative
Genome Analysis: Protein Phylogenetic Profiles (1999)
- A. S. Perelson, Mathematical Analysis of HIV-1 Dynamics in
Vivo (1999)
- N. G. Pakker, Biphasic kinetics of peripheral blood T cells
after triple combination therapy in HIV-1 infection: a composite of
redistribution and proliferation [see comments]. (1999)
- A. S. Perelson, HIV-1 dynamics in vivo: virion clearance
rate, infected cell life-span, and viral generation time. (1996)
- E. Pollak, Fixation probabilities when the population size
undergoes cyclic fluctuations (2000)
- R. J. Pomerantz, Residual HIV-1 disease in the era of highly
active antiretroviral therapy [editorial; comment] (1999)
- R. J. Pomeranz, Residual HIV-1 Disease in the Era of Highly
Active Antiretroviral Therapy (1999)
- G. Poli, Immunopathogenesis of Human Immunodeficiency Virus
Infection. (1993)
- R. W. Price, Cerebrospinal fluid response to structured
treatment interruption after virological failure (2001)
- B. D. Preston, Fidelity of HIV-1 reverse transcriptase (1988)
- H. J. P, Inferring the root of a phylogenetic tree (2000)
- T. Pupko, A fast algorithm for joint reconstruction of
ancestral amino acid sequences (2000)
- C. J. Pitcher, HIV-1-specific CD4+ T Cells are Detectable in
Most Individuals with Active HIV-1 Infection, but Decline with Prolonged
Viral Suppression (1999)
- H. J. P, Variation in the pattern of nucleotide substitution
across sites (1999)
- C. Piketty, Efficacy of a Five-Drug Combination Including
Ritonavir, Saquinavir and Efavirenz in Patients Who Failed on a Conventional
Triple-Drug Regimen: Phenotypic Resistance to Protease Inhibitors Predicts
Outcome of Therapy. (1999)
- N. G. Pakker, Patterns of T-cell repopulation, virus load
reduction, and restoration of T-cell function in HIV-infected persons during
therapy with different antiretroviral agents. (1997)
- H. J. P, Geographic Origin of Human Mitochondrial DNA:
Accommodating Phylogenetic Uncertainty and Model Comparison (2002)
- M. Piatak, High Levels of HIV-1 in Plasma During All Stages
of Infection Determined by Competitive PCR. (1993)
- C. Perez, [Molecular epidemiology of the human
immunodeficiency virus type 1 in Santiago, Chile] (1999)
- A. N. Phillips, Use of a stochastic model to develop
understanding of the impact of different patterns of antiretroviral drug use
on resistance development (2001)
- J. A. Partaledis, In Vitro Selection and Characterization of
Human Immunodeficiency Virus Type 1 (HIV-1) Isolates with Reduced Sensitivity
to Hydroxyethylamino Sulfonamide Inhibitors of HIV-1 Aspartyl Protease. (1995)
- Q
- R
- D. L. Robertson, HIV-1 Nomenclature Proposal (2000)
- B. Rannala, On the genealogy of a rare allele (1997)
- E. S. Rosenberg, Immune control of HIV-1 after early
treatment of acute infection (2000)
- M. Ricchetti, Reverse transcriptases and genomic variability:
the accuracy of DNA replicaiton is enzyme specific and sequence dependent (1990)
- R. M. Ribeiro, A stochastic model for primary HIV infection:
optimal timing of therapy (1999)
- R. M. Ribeiro, Production of resistant HIV mutants during
antiretroviral therapy (2000)
- J. R. Rosé, Defining the Level of Human Immunodeficiency
Virus Type 1 (HIV-1) Protease Activity Required for HIV-1 Particle Maturation
and Infectivity. (1995)
- J. D. Roberts, The accuracy of reverse transcriptase from
HIV-1 (1988)
- R. M. Ribeiro, The Frequency of Resistant Mutant Virus Before
Antiviral Therapy. (1998)
- L. Ruiz, HIV dynamics and T-cell immunity after three
structured treatment interruptions in chronic HIV-1 infection (2001)
- M. Robert-Guroff, HTLV-III-Neutralizing Antibodies in
Patients with AIDS and AIDS-Related Complex (1985)
- B. Renjifo, Emerging recombinant human immunodeficiency
viruses: uneven representation of the envelope V3 region (1999)
- D. L. Robertson, Intersubtype Recombinant HIV-1 Sequences (1997)
- A. Rambaut, Bi-De: an application for simulating phylogenetic
processes (1996)
- D. L. Robertson, Recombination in AIDS Viruses (1995)
- D. D. Richman, HIV chemotherapy (2001)
- M. S. Rosenberg, Incomplete taxon sampling is not a problem
for phylogenetic inference (2001)
- Ramirez, Clinical Failure of Highly Active Anti Retroviral
Therapy in HIV-1 Infected Patients (1999)
- M. D. Radmacher, Predicted and inferred waiting times for key
mutations in the germinal centre reaction: evidence for stochasticity in
selection. (1998)
- M. D. Radmacher, Predicted and Inferred Waiting Times for Key
Mutations in the Germinal Centre Reaction: Evidence for Stochasticity in
Selection (1998)
- T. Ridky, Development of drug resistance to HIV-1 protease
inhibitors. [review] (1995)
- L. Ruiz, Structured treatment interruption in chronically
HIV-1 infected patients after long-term viral suppression (2000)
- B. Ramratnam, The Decay of the Latent Reservoir of
Replication-Competent HIV-1 is Inversely Correlated with the extent of
Residual Viral Replication During Prolonged Anti-Retroviral Therapy (2000)
- A. Rzhetsky, Unbiased estimates of the number of nucleotide
substitutions when substitution rate varies among different sites (1994)
- A. G. Rodrigo, Calibrating the Bootstrap Test of Monophyly (1993)
- C. Rossi, A stochastic mover/stayer model for an HIV epidemic
(1991)
- N. R, Detecting positively selected amino acid sites using
posterior predictive P-values. (2002)
- B. T. R, Combined data, bayesian phylogenetics, and the
origin of the new zealand cicada genera (2002)
- S. C. Ray, Sex and the Genetic Diversity of HIV-1 (2000)
- D. E. Roberts, Comparison of different treatment regimens for
the emergence of new resistance under therap (2001)
- D. B. Rubin, Logit-Based Interval Estimation for Binomial
Data Using the Jeffreys Prior (1987)
- A. G. Rodrigo, Coalescent estimates of HIV-1 generation time
in vivo (1999)
- D. L. Robertson, Recombination in HIV-1 (1995)
- A. Ramos, Dual and recombinant infections: an integral part
of the HIV-1 epidemic in Brazil. (1999)
- D. B. Rubin, The Bayesian Bootstrap (1981)
- R. R. Regoes, Virus Dynamics: The Effect of Target Cell
Lmitation and Immune Responses on Virus Evolution. (1998)
- B. Rannala, Probability distribution of molecular
evolutionary trees: a new method of phylogenetic inference (1996)
- B. Reddy, Quantitative intracellular kinetics of HIV type 1.
(1999)
- S